Boost Energy, Metabolism, and Focus
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Definitely elevated my energy and focus I love the fact that the doctor called me immediately for consultation
Frequently Asked Questions Common side effects include pain at the injection site, swelling, redness, and mild allergic reactions like itching or rash
AHK-Cu, or Alanine-Histidine-Lysine-Copper, is a naturally occurring tripeptide complexed with copper that has been investigated for its role in activating copper-dependent enzymatic processes and modulating extracellular matrix proteins involved in tissue structure and repair
The Heavy periods and menopause may also contribute to B12 deficiency in females